Peroxisome proliferator-activated receptor-gamma (PPAR-gamma), the transcri
ption factor target of the anti-diabetic thiazolidinedione (TZD) drugs, is
reported to mediate macrophage differentiation and inflammatory responses.
Using PPAR-gamma -deficient stem cells, we demonstrate that PPAR-gamma is n
either essential for myeloid development, nor for such mature macrophage fu
nctions as phagocytosis and inflammatory cytokine production. PPAR-gamma is
required for basal expression of CD36, but not for expression of the other
major scavenger receptor responsible for uptake of modified lipoproteins,
SR-A. In wild-type macrophages, TZD treatment divergently regulated CD36 an
d class A macrophage-scavenger receptor expression and failed to induce sig
nificant cellular cholesterol accumulation, indicating that TZDs may not ex
acerbate macrophage foam-cell formation.